Window of Opportunity Trial of Neoadjuvant ADXS 11-001 Vaccination Prior to Robot -Assisted Resection of HPV-Positive Oropharyngeal Squamous Cell Carcinoma
Phase of Trial: Phase II
Latest Information Update: 05 Dec 2018
At a glance
- Drugs Axalimogene filolisbac (Primary)
- Indications Oropharyngeal cancer; Squamous cell cancer
- Focus Pharmacodynamics
- 27 Nov 2018 Planned End Date changed from 1 Aug 2019 to 1 Aug 2021.
- 27 Nov 2018 Planned primary completion date changed from 1 Aug 2018 to 1 Aug 2020.
- 31 Aug 2018 Biomarkers information updated